Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study

Movement Disorders

Volumn 16, Issue 5, 2001, Pages 830-837

  Benedetti, Maria D ^a   Maraganore, Demetrius M ^a   Bower, James H ^a   McDonnell, Shannon K ^a   Peterson, Brett J ^a   Ahlskog, J Eric ^a   Schaid, Daniel J ^a   Rocca, Walter A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Case control study; Epidemiology; Estrogen; Hysterectomy; Menopause; Parklinson's disease

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY MENOPAUSE; ESTROGEN THERAPY; FEMALE; FREQUENCY ANALYSIS; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; HYPOTHESIS; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENOPAUSE; ONSET AGE; OVARIECTOMY; PARKINSON DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AGED; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; HYSTERECTOMY; MEDICAL RECORD LINKAGE; MENOPAUSE, PREMATURE; MIDDLE AGED; MINNESOTA; PARKINSON DISEASE; RISK FACTORS;

EID: 0035470372     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1170     Document Type: Article

References (35)

1. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
2. Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson's disease and parkinsonism in a longitudinal study. Neurology 2000;55: 1358-1368.
3. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in Northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.
4. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA 1998;279:688-695.
5. Dluzen DE, McDermott JL, Liu B. Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem 1996;66:658-666.
6. Miller DB, Ali SF, O'Callaghan JP, Laws SC. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 1998;844:153-165.
7. Dluzen D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res 1997;767:340-344.
8. Bédard P, Boucher R, Di Paolo T, Labrie F. Interaction between estradiol, prolactin, and striatal dopaminergic mechanisms. Adv Neurol 1984;40:489-495.
9. Sandyk R. Estrogens and the pathophysiology of Parkinson's disease. Int J Neurosci 1989;45:119-122.
10. Thulin PC, Filoteo JV, Roberts JW, O'Brien SA. Effects of hormone replacement therapy on cognitive and motor function in women with Parkinson's disease [abstract]. Neurology 1998;50: A280.
11. Marder K, Tang M-X, Alfaro B, et al. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 1998;50:1141-1143.
12. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology 1999;52:1417-1421.
13. Shulman LM, Weiner WJ, Senneff MR. The effects of endogenous and exogenous estrogen exposure in patients with Parkinson's disease [abstract]. Mov Disord 1998;13:A64.
14. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;49:1284-1288.
15. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
16. Melton LJ, III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
17. Commission on Professional and Hospital Activities. Hospital adaptation of ICDA-H-ICDA, 2nd ed. Ann Arbor, MI: Commission on Professional and Hospital Activities; 1973.
18. Phillips SJ, Whisnant JP, O'Fallon WM, Hickman RD. A community blood pressure survey: Rochester, Minnesota, 1986. Mayo Clin Proc 1988;63:691-699.
19. Campion ME, Naessens JM, Leibson CL, Shaller D, Ballard DJ. The Olmsted County Benchmark Project: Primary study findings and potential implications for corporate America. Mayo Clin Proc 1992;67:5-14.
20. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1-the analysis of case-control studies. IARC Scientific Publications No. 32. Lyon: International Agency for Research on Cancer; 1980.
21. Treloar AE. Menarche, menopause, and intervening fecundability. Hum Biol 1974;46:89-107.
22. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1986;47:94-100.
23. Schlesselman JJ, Stolley PD. Case-control studies. Design, conduct, analysis. New York: Oxford University Press; 1982.
24. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
25. Sackett DL. Bias in analytic research. J Chron Dis 1979;32:51-63.
26. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000;15:669-677.
27. Bukovsky I, Halperin R, Schneider D, Golan A, Hertzianu I, Herman A. Ovarian function following abdominal hysterectomy with and without unilateral oophorectomy. Eur J Obstet Gynecol Reprod Biol 1995;58:29-32.
28. Lindsay MK, Usher DJ. Unrecognized ovarian failure after hysterectomy. Br J Gen Pract 1992;42:529-530.
29. Oldenhave A, Jaszmann LJB, Everaerd WThAM, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993;168:765-771.
30. Stone SC, Dickey RP, Mickal A. The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol 1975;121:193-197.
31. Janson PO, Janssen I. The acute effect of hysterectomy on ovarian blood flow. Am J Obstet Gynecol 1977;127:349-352.
32. Cattanach J. Oestrogen deficiency after tubal ligation. Lancet 1985;1:847-849.
33. Parazzini F, Braga C, La Vecchia C, Negri E, Acerboni S, Franceschi S. Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol 1997;90:453-456.
34. Feinstein AR. Clinical epidemiology. The architecture of clinical research. New Haven, Connecticut: Yale University School of Medicine; 1985.
35. 18F] dopa PET. J Neurol Neurosurg Psychiatry 1998;64:314-319.